De-identification is one control, not the whole answer
Regenemm Healthcare's current framing treats non-identifiable data as part of a wider privacy model that includes minimisation, access control, provenance, review and safe handling of clinical context.
Risk reduction
Removing identifiers can reduce exposure, but it does not remove the need for privacy review.
Context control
Clinical context should be handled carefully because combinations of details can still carry sensitivity.
Purpose limits
Data use should stay aligned with the care, quality or governance purpose it was approved for.
Access boundaries
Non-identifiable datasets still need permission-aware storage, processing and sharing controls.
Provenance
Teams should know where data came from, how it was transformed and which controls apply.
Review cycle
Privacy assumptions should be revisited as systems, datasets and workflows change.